89bio's market cap is currently ―. The company's EPS TTM is $-2.01; its P/E ratio is -3.93; 89bio is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -35.50M	$ -33.77M	$ -37.50M	$ -26.76M	$ -24.83M
EBITDA	$ -35.49M	$ -35.68M	$ -38.46M	$ -27.61M	$ -25.03M
Net Income Common Stockholders	$ -40.23M	$ -34.73M	$ -38.39M	$ -28.84M	$ -24.60M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 578.87M	$ 251.93M	$ 245.44M	$ 350.93M	$ 55.26M
Total Assets	$ 596.27M	$ 460.11M	$ 492.51M	$ 494.24M	$ 196.82M
Total Debt	$ 27.11M	$ 24.87M	$ 24.75M	$ 24.64M	$ 20.05M
Net Debt	$ -551.76M	$ -227.06M	$ -220.69M	$ -326.29M	$ -35.21M
Total Liabilities	$ 59.96M	$ 49.90M	$ 50.52M	$ 48.49M	$ 44.99M
Stockholders Equity	$ 536.31M	$ 410.21M	$ 441.99M	$ 445.83M	$ 151.83M
Cash Flow	-
Free Cash Flow	$ -34.30M	$ -30.36M	$ -34.45M	$ -30.09M	-
Operating Cash Flow	$ -34.29M	$ -30.36M	$ -34.45M	$ -30.09M	-
Investing Cash Flow	$ -63.64M	$ 38.33M	$ -101.81M	$ 4.11M	-
Financing Cash Flow	$ 162.17M	$ -1.48M	$ 30.77M	$ 321.65M	-

Currency in USD

89bio Earnings and Revenue History

Income Statement >

89bio Debt to Assets

Balance Sheet >

89bio Cash Flow

Cash Flow >

89bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing